IL-1 and CD40/CD40L platelet complex: elements of induction of Crohn’s disease and new therapeutic targets
Autor: | Fatima Zahra Marhoume, Loubna Khalki, Nabil Zaid, Mounia Oudghiri, Y. Tijani, Nezha Senhaji, Asmae Aouiss, Younes Zaid, Abdallah Naya, Doha Anka Idrissi, Mostafa Kabine |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Crohn's disease business.industry Organic Chemistry Inflammation Disease medicine.disease Acquired immune system medicine.disease_cause Ulcerative colitis digestive system diseases Autoimmunity 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Intestinal mucosa 030220 oncology & carcinogenesis Drug Discovery Immunology medicine Genetic predisposition Molecular Medicine medicine.symptom business |
Zdroj: | Archives of Pharmacal Research. 44:117-132 |
ISSN: | 1976-3786 0253-6269 |
Popis: | Ulcerative colitis (UC) and Crohn's disease (CD) are chronic and multifactorial diseases that affect the intestinal tract, both characterized by recurrent inflammation of the intestinal mucosa, resulting in abdominal pain, diarrhea, vomiting and, rectal bleeding. Inflammatory bowel diseases (IBD) regroup these two disorders. The exact pathological mechanism of IBD remains ambiguous and poorly known. In genetically predisposed patients, defects in intestinal mucosal barrier are due to an uncontrolled inflammatory response to normal flora. In addition to the genetic predisposition, these defects could be triggered by environmental factors or by a specific lifestyle which is widely accepted as etiological hypothesis. The involvement of the CD40/CD40L platelet complex in the development of IBD has been overwhelmingly demonstrated. CD40L is climacteric in cell signalling in innate and adaptive immunity, the CD40L expression on the platelet cell surface gives them an immunological competence. The IL-1, a major inflammation mediator could be involved in different ways in the development of IBD. Here, we provide a comprehensive review regarding the role of platelet CD40/CD40L in the pathophysiological effect of IL-1 in the development of Crohn's disease (CD). This review could potentially help future approaches aiming to target these two pathways for therapeutic purposes and elucidate the immunological mechanisms driving gut inflammation. |
Databáze: | OpenAIRE |
Externí odkaz: |